Kaustuva Das
@kaustuvadas.bsky.social
CEO, Thermal + PR for Jennifer Doudna, Nobel laureate and CRISPR pioneer
thermalpr.com
thermalpr.com
7/ 📰 The New York Times
www.nytimes.com/2025/05/15/h...
TIME
time.com/7285695/firs...
WIRED
www.wired.com/story/a-baby...
NPR
www.npr.org/sections/sho...
The Washington Post
www.washingtonpost.com/science/2025...
Endpoints News
endpts.com/philadelphia...
STAT
www.statnews.com/2025/05/15/c...
www.nytimes.com/2025/05/15/h...
TIME
time.com/7285695/firs...
WIRED
www.wired.com/story/a-baby...
NPR
www.npr.org/sections/sho...
The Washington Post
www.washingtonpost.com/science/2025...
Endpoints News
endpts.com/philadelphia...
STAT
www.statnews.com/2025/05/15/c...
Baby Is Healed With World’s First Personalized Gene-Editing Treatment
www.nytimes.com
May 16, 2025 at 3:57 AM
7/ 📰 The New York Times
www.nytimes.com/2025/05/15/h...
TIME
time.com/7285695/firs...
WIRED
www.wired.com/story/a-baby...
NPR
www.npr.org/sections/sho...
The Washington Post
www.washingtonpost.com/science/2025...
Endpoints News
endpts.com/philadelphia...
STAT
www.statnews.com/2025/05/15/c...
www.nytimes.com/2025/05/15/h...
TIME
time.com/7285695/firs...
WIRED
www.wired.com/story/a-baby...
NPR
www.npr.org/sections/sho...
The Washington Post
www.washingtonpost.com/science/2025...
Endpoints News
endpts.com/philadelphia...
STAT
www.statnews.com/2025/05/15/c...
6/ 📕 NEJM paper www.nejm.org/doi/full/10....
📺 The IGI’s announcement innovativegenomics.org/news/first-p... and video about CRISPR on-demand, a first in the history of medicine www.youtube.com/watch?v=H7pj...
📺 CHOP's announcement page with videos www.chop.edu/centers-prog...
📺 The IGI’s announcement innovativegenomics.org/news/first-p... and video about CRISPR on-demand, a first in the history of medicine www.youtube.com/watch?v=H7pj...
📺 CHOP's announcement page with videos www.chop.edu/centers-prog...
Patient-Specific In Vivo Gene Editing to Treat a Rare Genetic Disease | NEJM
Base editors can correct disease-causing genetic variants. After a neonate had received a diagnosis of severe carbamoyl-phosphate synthetase 1 deficiency, a disease with an estimated 50% mortality ...
www.nejm.org
May 16, 2025 at 3:57 AM
6/ 📕 NEJM paper www.nejm.org/doi/full/10....
📺 The IGI’s announcement innovativegenomics.org/news/first-p... and video about CRISPR on-demand, a first in the history of medicine www.youtube.com/watch?v=H7pj...
📺 CHOP's announcement page with videos www.chop.edu/centers-prog...
📺 The IGI’s announcement innovativegenomics.org/news/first-p... and video about CRISPR on-demand, a first in the history of medicine www.youtube.com/watch?v=H7pj...
📺 CHOP's announcement page with videos www.chop.edu/centers-prog...
5/ This landmark achievement was made possible by @kiranmusunuru.bsky.social at @pennmedicine.bsky.social, @ahrensnicklas.bsky.social at Children's Hospital of Philadelphia, @urnov.bsky.social and @innovativegenomics.bsky.social team, Danaher, and more.
May 16, 2025 at 3:57 AM
5/ This landmark achievement was made possible by @kiranmusunuru.bsky.social at @pennmedicine.bsky.social, @ahrensnicklas.bsky.social at Children's Hospital of Philadelphia, @urnov.bsky.social and @innovativegenomics.bsky.social team, Danaher, and more.
4/ @jenniferdoudna.bsky.social, #CRISPR co-inventor and Nobel laureate, said of the milestone, “This was a remarkable team effort. The ability to develop an on-demand CRISPR therapy in such a short time opens up a new era for treating previously untreatable genetic diseases.”
May 16, 2025 at 3:57 AM
4/ @jenniferdoudna.bsky.social, #CRISPR co-inventor and Nobel laureate, said of the milestone, “This was a remarkable team effort. The ability to develop an on-demand CRISPR therapy in such a short time opens up a new era for treating previously untreatable genetic diseases.”
3/
The patient, KJ, was born with CPS1 deficiency, a rare and severe metabolic disease affecting 1 in 1.3 million newborns. In just 6 months, scientists and doctors designed a CRISPR treatment that specifically targeted a genetic mutation in KJ’s liver cells.
The patient, KJ, was born with CPS1 deficiency, a rare and severe metabolic disease affecting 1 in 1.3 million newborns. In just 6 months, scientists and doctors designed a CRISPR treatment that specifically targeted a genetic mutation in KJ’s liver cells.
May 16, 2025 at 3:57 AM
3/
The patient, KJ, was born with CPS1 deficiency, a rare and severe metabolic disease affecting 1 in 1.3 million newborns. In just 6 months, scientists and doctors designed a CRISPR treatment that specifically targeted a genetic mutation in KJ’s liver cells.
The patient, KJ, was born with CPS1 deficiency, a rare and severe metabolic disease affecting 1 in 1.3 million newborns. In just 6 months, scientists and doctors designed a CRISPR treatment that specifically targeted a genetic mutation in KJ’s liver cells.
2/
- This was medically vital, developed as a Manhattan Project for genetic medicine.
- It’s an N-of-1 therapy, a proof of concept showing how scientists can unite around a patient in need.
- It affirms the goal: Create scalable on-demand personalized CRISPR therapies accessible to all patients.
- This was medically vital, developed as a Manhattan Project for genetic medicine.
- It’s an N-of-1 therapy, a proof of concept showing how scientists can unite around a patient in need.
- It affirms the goal: Create scalable on-demand personalized CRISPR therapies accessible to all patients.
May 16, 2025 at 3:57 AM
2/
- This was medically vital, developed as a Manhattan Project for genetic medicine.
- It’s an N-of-1 therapy, a proof of concept showing how scientists can unite around a patient in need.
- It affirms the goal: Create scalable on-demand personalized CRISPR therapies accessible to all patients.
- This was medically vital, developed as a Manhattan Project for genetic medicine.
- It’s an N-of-1 therapy, a proof of concept showing how scientists can unite around a patient in need.
- It affirms the goal: Create scalable on-demand personalized CRISPR therapies accessible to all patients.